Skip to main content

F Squadrito

First name:
F
Last name:
Squadrito
Burnett, B. P., Pillai, L., Bitto, A., Squadrito, F., & Levy, R. M. Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women. International Journal Of Women's Health, 3, 139-50. https://doi.org/10.2147/IJWH.S19309 (Original work published 2011)
Burnett, B. P., Bitto, A., Altavilla, D., Squadrito, F., Levy, R. M., & Pillai, L. Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant. Mediators Of Inflammation, 2011, 385780. https://doi.org/10.1155/2011/385780 (Original work published 2011)
Bitto, A., Bagnato, G. L., Pizzino, G., Roberts, W. N., Irrera, N., Minutoli, L., et al. (2016). SIMVASTATIN PREVENTS VASCULAR COMPLICATIONS IN THE CHRONIC REACTIVE OXYGEN SPECIES MURINE MODEL OF SYSTEMIC SCLEROSIS. Free Radical Research, 1-28. https://doi.org/10.3109/10715762.2016.1149171 (Original work published 2016)
Bagnato, G. L., Irrera, N., Pizzino, G., Santoro, D., Roberts, W. N., Bagnato, G., et al. (2018). Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis. Clinical Science (London, England : 1979), 132(2), 231-242. https://doi.org/10.1042/CS20171426 (Original work published 2018)
Bagnato, G., Pigatto, E., Bitto, A., Pizzino, G., Irrera, N., Abignano, G., et al. The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis. Frontiers In Medicine, 8, 651748. https://doi.org/10.3389/fmed.2021.651748 (Original work published 2021)